Cite
MLA Citation
Christian U. Blank et al.. “Open-label, multicentre safety study of vemurafenib in 3219 patients with BRAFV600 mutation-positive metastatic melanoma: 2-year follow-up data and long-term responders' analysis.” European journal of cancer, vol. 79, 2017, pp. 176–184. http://access.bl.uk/ark:/81055/vdc_100047035917.0x00002d